$0.3190
0.062224.22%
Last update: Nov 10, 9:17 AM
Co-Diagnostics Inc
CODXNASDAQ
Co-Diagnostics fell 97.3% from $11.71 to $0.32, behind the S&P 500's +10.5%. Its worst day was Jan 13 (−60.5%), and its low came Nov 6 at $0.26.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-4.80 beat the $-5.70 estimate on $145,380.00 revenue (est. $300,000.00).
−10.9% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
On January 7, 2026, Co-Diagnostics, Inc.
−60.5%, the year's worst day · S&P 500 −0.2%
Co-Diagnostics shares rose 101.8%, while the S&P 500 fell 0.2%.
+101.8%, the year's best day · S&P 500 −0.2%
EPS of $-16.65 missed the $-3.90 estimate on $263,922.00 revenue (est. $150,000.00).
−12.9% · S&P 500 +0.8%
EPS of $-4.06 missed the $-3.60 estimate on $145,954.00 revenue (est. $200,000.00).
−21.2% · S&P 500 −1.2%
Co-Diagnostics shares rose 79.7%, while the S&P 500 rose 0.7%.
+79.7% · S&P 500 +0.7%
EPS of $-1.46 beat the $-3.00 estimate on $166,131.00 revenue (est. $200,000.00).
−6.0% · S&P 500 −0.2%
Where it ended: a close of $0.32 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 10, 2026 (EPS est. $-2.40, revenue est. $200,000.00).
Nothing in the past 12 months.
All CODX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CODX and SPY from Benzinga historical bars. Not investment advice.
